Ann MacLaren

1.0k total citations
23 papers, 840 citations indexed

About

Ann MacLaren is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ann MacLaren has authored 23 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Ann MacLaren's work include Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Ann MacLaren is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Ann MacLaren collaborates with scholars based in United Kingdom, United States and Australia. Ann MacLaren's co-authors include David Pollock, Gilles Mithieux, David A. Gillespie, Catherine A. Dunn, Carolyn Wiltshire, Mohit Trikha, William Clark, Elizabeth J. Black, Rachel Chapman and A H Wyllie and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Ann MacLaren

21 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann MacLaren United Kingdom	10	571	183	130	126	112	23	840
Ellen Barnes United States	8	550 1.0×	118 0.6×	100 0.8×	87 0.7×	65 0.6×	10	769
J. D. Rothermel United States	14	492 0.9×	232 1.3×	179 1.4×	94 0.7×	46 0.4×	24	930
I Magnaldo France	13	640 1.1×	79 0.4×	219 1.7×	91 0.7×	113 1.0×	14	917
Sara Caldarola Italy	15	704 1.2×	191 1.0×	76 0.6×	67 0.5×	41 0.4×	19	1.1k
Bryan Mitton United States	16	674 1.2×	148 0.8×	94 0.7×	107 0.8×	55 0.5×	28	1.0k
Hee‐Don Chae United States	18	659 1.2×	231 1.3×	98 0.8×	86 0.7×	80 0.7×	40	1.0k
Angela McCahill United Kingdom	12	839 1.5×	87 0.5×	90 0.7×	105 0.8×	28 0.3×	17	1.0k
Enric Poch Spain	13	309 0.5×	89 0.5×	41 0.3×	100 0.8×	73 0.7×	22	560
Thomas Harnois France	14	365 0.6×	78 0.4×	176 1.4×	53 0.4×	45 0.4×	22	617
Eva Richard Spain	23	820 1.4×	80 0.4×	103 0.8×	87 0.7×	25 0.2×	61	1.2k

Countries citing papers authored by Ann MacLaren

Since Specialization

Citations

This map shows the geographic impact of Ann MacLaren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann MacLaren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann MacLaren more than expected).

Fields of papers citing papers by Ann MacLaren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann MacLaren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann MacLaren. The network helps show where Ann MacLaren may publish in the future.

Co-authorship network of co-authors of Ann MacLaren

This figure shows the co-authorship network connecting the top 25 collaborators of Ann MacLaren. A scholar is included among the top collaborators of Ann MacLaren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann MacLaren. Ann MacLaren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacLaren, Ann, Nathan W. Levin, & Henry B. Lowman. (2018). Abstract 835: TRPH-222, a novel anti-CD22 antibody drug conjugate (ADC), has significant anti-tumor activity in NHL xenografts and reduces B cells in monkeys. Cancer Research. 78(13_Supplement). 835–835. 5 indexed citations

MacLaren, Ann, Nathan W. Levin, Henry B. Lowman, & Mohit Trikha. (2017). Trph-222, a Novel Anti-CD22 Antibody Drug Conjugate (ADC), Has Signficant Anti-Tumor Activity in NHL Xenografts and Is Well Tolerated in Non-Human Primates. Blood. 130. 4105–4105. 5 indexed citations

Spencer, Andrew, Simon J. Harrison, Jeffrey A. Zonder, et al.. (2017). A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results. British Journal of Haematology. 180(1). 41–51. 60 indexed citations

Badros, Ashraf, Zeba N. Singh, Binod Dhakal, et al.. (2017). Marizomib for central nervous system‐multiple myeloma. British Journal of Haematology. 177(2). 221–225. 50 indexed citations

Spencer, Andrew, Simon J. Harrison, Jacob P. Laubach, et al.. (2016). Pmd-107: Marizomib, Pomalidomide and Low Dose-Dexamethasone Combination Study in Relapsed/Refractory Multiple Myeloma (NCT02103335): Full Enrollment Results from a Phase-1 Multicenter, Open Label Study. Blood. 128(22). 3326–3326. 7 indexed citations

Bota, Daniela A., Annick Desjardins, Warren Mason, et al.. (2016). Abstract 3069: Investigation of pharmacodynamic and predictive biomarkers to define response to proteasome inhibitor marizomib in glioma. Cancer Research. 76(14_Supplement). 3069–3069. 1 indexed citations

Di, Kaijun, G. Kenneth Lloyd, Ann MacLaren, et al.. (2015). Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. Neuro-Oncology. 18(6). 840–848. 107 indexed citations

Shehata, Medhat, Susanne Schnabl, Stefanie Tauber, et al.. (2009). Lumiliximab Triggers Apoptosis Mechanisms in CLL Cells through the Inhibition of PI3-K/Akt Pathway.. Blood. 114(22). 2371–2371.

MacLaren, Ann, Daniela A Slavin, & Clare H. McGowan. (2009). Chk2 Protects against Radiation-Induced Genomic Instability. Radiation Research. 172(4). 463–463. 5 indexed citations

10.

MacLaren, Ann, Elizabeth J. Black, William Clark, & David A. Gillespie. (2004). c-Jun-Deficient Cells Undergo Premature Senescence as a Result of Spontaneous DNA Damage Accumulation. Molecular and Cellular Biology. 24(20). 9006–9018. 52 indexed citations

11.

MacLaren, Ann, William Clark, Elizabeth J. Black, et al.. (2003). v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1. Oncogene. 22(16). 2383–2395. 10 indexed citations

12.

Black, Elizabeth J., Mark Walker, William Clark, Ann MacLaren, & David A. Gillespie. (2002). Cell transformation by v-Jun deactivates ERK MAP kinase signalling. Oncogene. 21(42). 6540–6548. 14 indexed citations

13.

Gordon, Katrina, et al.. (2002). Beatson International Cancer Conference: Genomic Regulation and Cancer. British Journal of Cancer. 86(5). 665–668. 1 indexed citations

14.

MacLaren, Ann, Rachel Chapman, A H Wyllie, & Christine J. Watson. (2001). p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death and Differentiation. 8(3). 210–218. 66 indexed citations

15.

Clark, William, Elizabeth J. Black, Ann MacLaren, et al.. (2000). v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity. Molecular and Cellular Biology. 20(7). 2529–2542. 23 indexed citations

16.

MacLaren, Ann, William Clark, & David A. Gillespie. (2000). v-Jun sensitizes cells to apoptosis by a mechanism involving mitochondrial cytochrome C release. Oncogene. 19(51). 5906–5918. 7 indexed citations

17.

MacLaren, Ann, Derek McBride, Christine J. Watson, & Michael Clinton. (1996). Identification of Transcripts Showing Differential Expression In The Developing Mammary Gland Using Differential Display. Biochemical Society Transactions. 24(3). 372S–372S. 1 indexed citations

18.

MacLaren, Ann, et al.. (1970). Segmental stimulation of spinal autonomic outflows in the pithed cat and rat.. PubMed. 211(2). Suppl:11P+–Suppl:11P+. 6 indexed citations

19.

Mithieux, Gilles, Ann MacLaren, & David Pollock. (1970). A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. British Journal of Pharmacology. 40(2). 257–267. 237 indexed citations

20.

Mithieux, Gilles, Ann MacLaren, & David Pollock. (1969). A method of stimulating different segments of the sympathetic and parasympathetic outflows from the spinal cord in the pithed rat.. PubMed. 37(2). 513P–514P. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact